Warning: fopen(/home/virtual/epih/journal/upload/ip_log/ip_log_2024-12.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96 Associations of cumulative average dietary total antioxidant capacity and intake of antioxidants with metabolic syndrome risk in Korean adults aged 40 years and older: a prospective cohort study (KoGES_CAVAS)
Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Epidemiol Health > Volume 45; 2023 > Article
Original Article
 Associations of cumulative average dietary total antioxidant capacity and intake of antioxidants with metabolic syndrome risk in Korean adults aged 40 years and older: a prospective cohort study (KoGES_CAVAS)
Ji-Sook Kong1,2orcid, Jiseon Lee1,2orcid, Youngjun Kim1,2,3orcid, Hye Won Woo1,2orcid, Min-Ho Shin4orcid, Sang Baek Koh5orcid, Hyeon Chang Kim6orcid, Yu-Mi Kim1,2,3orcid, Mi Kyung Kim1,2,3orcid
Epidemiol Health 2023;45:e2023067.
DOI: https://doi.org/10.4178/epih.e2023067
Published online: July 28, 2023

1Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea

2Institute for Health and Society, Hanyang University, Seoul, Korea

3Department of Public Health Sciences, Hanyang University, Seoul, Korea

4Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Korea

5Department of Preventive Medicine and Institute of Occupational Medicine, Yonsei Wonju College of Medicine, Wonju, Korea

6Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea

Correspondence: Mi Kyung Kim Department of Preventive Medicine, Hanyang University College of Medicine, 222 Wangsimni-ro, Sungdong-gu, Seoul 04763, Korea E-mail: kmkkim@hanyang.ac.kr
• Received: February 22, 2023   • Accepted: July 4, 2023

© 2023, Korean Society of Epidemiology

This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • 6,576 Views
  • 138 Download
  • 3 Web of Science
  • 2 Crossref
  • 2 Scopus
Full Article

Download PDF Download PDF

  • OBJECTIVES
    Limited and inconsistent prospective evidence exists regarding the relationship of dietary total antioxidant capacity (dTAC) and antioxidant intake with metabolic syndrome (MetS) risk. We evaluated the associations of the cumulative averages of dTAC and antioxidant intake (in 5 classes: retinol, vitamin C, vitamin E, carotenoids, and flavonoids, as well as 7 flavonoid subclasses) with the risk of MetS.
  • METHODS
    This study included 11,379 participants without MetS, drawn from the Korean Genome and Epidemiology Study_CArdioVascular disease Association Study (KoGES_CAVAS). The cumulative average consumption was calculated using repeated food frequency questionnaires. Incidence rate ratios were estimated using a modified Poisson regression model with a robust error estimator.
  • RESULTS
    The median follow-up period was 5.16 years, and 2,416 cases of MetS were recorded over 58,750 person-years. In men, significant inverse associations were observed in all 5 antioxidant classes, except for the highest quartile of dTAC. In women, dTAC and total flavonoids were not significantly associated with MetS; however, significant L-shaped associations were found for the remaining 4 antioxidant classes. Of the 7 flavonoid subclasses, only flavones in the highest quartile for men and flavan-3-ols in women lacked significant associations with MetS. The inverse associations were not sex-specific, but they were particularly pronounced among participants with a body mass index (BMI) of 23 kg/m2 or higher.
  • CONCLUSIONS
    The findings suggest that most antioxidant classes and flavonoid subclasses, unlike dTAC, exhibit a clear beneficial association with MetS in an L-shaped pattern in both men and women, particularly those with a high BMI.
  • Keywords: Antioxidants, Flavonoids, Vitamins, Metabolic syndrome, Obesity, Cohort study
Metabolic syndrome (MetS) is a cluster of medical conditions that include abdominal obesity, insulin resistance, hypertension, and hyperlipidemia [1]. It is associated with an increased risk of mortality and morbidity, such as cardiovascular disease (CVD) and diabetes [2]. The prevalence of MetS fluctuates based on the definitions used, but it is estimated to affect 10% to 40% of the global population, equating to over 1 billion people worldwide [2,3]. Therefore, identifying modifiable risk factors for MetS could aid in reducing the global burden of the disease.
Oxidative stress may play a pathogenic role in the development and progression of MetS and its associated abnormalities [4]. Antioxidants can potentially counteract this oxidative damage by scavenging reactive free radicals in the body [5,6]. Extensive research has been conducted on the relationships of antioxidants or antioxidant-rich foods with various health outcomes [7]. However, these studies have been focused on individual antioxidants or specific foods, resulting in inconsistent findings. This inconsistency may stem in part from the varying types and amounts of antioxidants found in different foods, which can affect their overall antioxidant capacities [5,6]. To address these challenges, the concept of dietary total antioxidant capacity (dTAC) was introduced. This index represents the summed antioxidant capacity (AC) of all consumed foods [8]. Since its introduction, dTAC has been studied in relation to several health outcomes, including risk factors for CVD [9]. In Korea, research has also explored its cross-sectional association with dyslipidemia [10] and prospective association with diabetes [11]. However, limited evidence is available regarding the relationship between dTAC and MetS, with most studies being cross-sectional and primarily conducted in Western countries [9,12]. In addition to dTAC, the association between the antioxidants (5 antioxidant classes and 7 flavonoid subclasses) used to calculate dTAC [8] and MetS remains unclear [12]. A recent review suggested that, based on animal studies, the antioxidant quercetin may have beneficial effects on insulin resistance, inflammation, and blood pressure (BP) in obese individuals [13]. Our previous study on flavonoids and the risk of incident hypertension also revealed significant interactions of anthocyanins and proanthocyanidins with hypertension risk based on obesity status [14]. However, it remains unclear whether the associations of dTAC and antioxidant intake with MetS risk vary depending on obesity status.
Therefore, in this study, we aimed to assess the relationships of both dTAC and antioxidant intake (encompassing 5 classes: retinol, vitamin C, vitamin E, carotenoids, and flavonoids, as well as 7 flavonoid subclasses: flavonols, flavones, flavanones, flavan-3-ols, anthocyanins, isoflavones, and proanthocyanidins) with the risk of MetS among adults aged 40 years or older in a prospective cohort. Additionally, we attempted to identify any obesity-specific associations.
Study design and population
The Korean Genome and Epidemiology Study_Cardiovascular Disease Association Study (KoGES_CAVAS) is a comprehensive investigation of cardiovascular health risk factors among Koreans, combining 3 distinct cohorts [15]. These cohorts include the MultiRural Communities Cohort (MRCohort), the Atherosclerosis Risk of Rural Areas in the Korean General Population (ARIRANG) cohort, and the Kangwha cohort. These cohorts have been included in the KoGES since 2005. Each cohort consists of community residents aged 40 years and older, recruited through multistage cluster sampling from 6 counties: Yangpyeong, Namwon, and Goryeong for the MRCohort; Wonju and Pyeongchang for ARIRANG; and Kangwha. Between 2005 and 2011, 19,546 participants with neither CVD nor cancer were enrolled in a baseline survey. Follow-up was conducted every 2-4 years from 2007 to 2017, with 78.2% of participants having more than 1 revisit.
We excluded participants with the following conditions at baseline: (1) those who already had prevalent MetS (n = 7,709) or lacked MetS identification information at baseline (n= 56); (2) those who left ≥ 10 items unanswered on the food frequency questionnaire (FFQ) or had an implausible energy intake (≤ 619 or ≥ 4,032 kcal/day in men and ≤ 509 or ≥ 3,918 kcal/day in women, representing cut-offs of the ≤ 0.5th or ≥ 99.5th percentiles of total energy intake) (n= 202); and (3) those with missing data for important covariates (n= 200), such as education level (n= 31), smoking status (n= 25), regular exercise (n= 123), drinking status (n= 17), and/or body mass index (BMI, kg/m2) (n= 12). The final analysis included 11,379 participants, with 4,422 men and 6,957 women.
Ascertainment of metabolic syndrome
Five components of MetS were measured as follows. Waist circumference (WC) was determined at the midpoint between the bottom of the rib margin and the iliac crest. BP measurements were taken was measured twice from the right arm using a standard mercury sphygmomanometer in the MRCohort (Baumanometer; WA Baum Co., Inc., Copiague, NY, USA) and the ARIRIANG cohort (Baumanometer and CK-101, Spirit Medical Co., New Taipei City, Taiwan) and an automatic sphygmomanometer in the Kangwha cohort (Dinamap 1846 SX/P; Critikon, Tampa, FL, USA). These measurements were taken after the participants had been seated for at least 5 minutes to ensure stable readings. If a difference of more than 5 mmHg was observed between 2 consecutive systolic blood pressure (SBP) or diastolic blood pressure (DBP) readings, additional measurements were taken, and the average values were used for analysis. However, in the ARIRIANG cohort, more than half of the initial BP measurements were taken only once (56.2%) prior to joining KoGES_CAVAS, so these single readings were used. Blood samples were collected after a minimum of 8 hours of fasting. The serum concentrations of high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and fasting blood glucose (FBG) were then quantified using an ADVIA 1650 automated analyzer (Siemens, New York, NY, USA).
MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria [16], but with a modified definition of abdominal obesity as per the Korean Society for the Study of Obesity [17]. To be categorized as having MetS, individuals had to meet at least 3 of the following 5 criteria at baseline: (1) a WC ≥ 90 cm for men and ≥ 85 cm for women; (2) elevated BP, specifically SBP ≥ 130 mmHg and/or DBP ≥ 85 mmHg, or the use of antihypertensive medication; (3) an elevated FBG level of ≥ 100 mg/dL or the use of medication for diabetes mellitus; (4) an elevated TG level, defined as ≥ 150 mg/dL; and (5) a reduced HDL-C level, defined as < 40 mg/dL for men and < 50 mg/dL for women.
Incident cases of MetS were identified using the same criteria as the baseline definition, namely the presence of at least 3 of the 5 risk factors at each follow-up visit. The earliest diagnosis of MetS was considered the incident event.
Dietary assessment: total antioxidant capacity and nutrients
Food intake was assessed by highly trained interviewers using a validated FFQ comprising 106 food items. The validity of this FFQ was confirmed by de-attenuated correlation coefficients, which ranged from 0.23 for vitamin A (RE) to 0.64 for carbohydrates, with a median value of 0.39. The coefficients were 0.31 for beta-carotene and 0.34 for vitamin C [18]. Participants were asked to recall the frequency of consumption and average portion size of each food item they consumed over the past year. To aid comprehension and ensure study reliability, photographs of typical portion sizes were provided. The response options for each item included 9 frequency categories, from “never or rarely” to “3 times per day,” and 3 portion sizes. Daily nutrient intake was calculated using weighted frequencies per day and portion sizes per unit for each food item, based on the nutrient database found in the seventh edition of the Korean Food Composition Table [19].
To calculate dTAC, we constructed a database for antioxidants and total antioxidant capacity (TAC), incorporating 5 classes of antioxidants (retinol, vitamin C, vitamin E, carotenoids, and flavonoids) and 7 subclasses of flavonoids (flavonols, flavones, flavanones, flavan-3-ols, anthocyanins, isoflavones, and proanthocyanidins). We utilized food composition tables and databases provided by the government and authorized institutions. For vitamins and carotenoids, our primary source was the Food and Nutrient Database of the Korea Ministry of Food and Drug Safety [20], followed by the United States Department of Agriculture (USDA) Standard Reference (SR28, release 28) [21] and the Japanese Standard Tables of Food Composition (seventh revised edition) [22]. For flavonoids, we referenced 3 separate USDA databases—release 3.3 for flavonoids [23], release 2.1 for isoflavones [24], and release 2.1 for proanthocyanidins [25]—followed by the PhenolExplorer 3.6 database [26].
In total, 42 antioxidants were used: retinol, vitamin C, 4 forms of vitamin E (α-tocopherol, β-tocopherol, γ-tocopherol, and δ-tocopherol), 5 carotenoids (α-carotene, β-carotene, lycopene, β-cryptoxanthin, and lutein+zeaxanthin), and 31 flavonoids. Among the 31 flavonoids, 7 subclasses were included: 4 flavonols (quercetin, kaempferol, myricetin, and isorhamnetin), 2 flavones (luteolin and apigenin), 3 flavanones (hesperetin, naringenin, and eriodictyol), 10 flavan-3-ols (catechin, epicatechin, epigallocatechin, epicatechin 3-gallate, epigallocatechin 3-gallate, theaflavin, thearubigin, theaflavin 3-gallate, theaflavin 3´-gallate, and theaflavin 3,3´-digallate), 6 anthocyanins (cyanidin, delphinidin, malvidin, pelargonidin, peonidin, and petunidin), 4 isoflavones (daidzein, genistein, glycitein, and biochanin), and 2 proanthocyanidins (dimers and trimers). The antioxidant database covers approximately 60.9% of flavonoids, 92.2% of carotenoids, and over 99% of retinol, vitamin C, and vitamin E. The individual TAC of each food item (measured in mg vitamin C equivalent [VCE]/100 g) was calculated as the sum of the product of antioxidant content and antioxidant capacity of the individual antioxidants [8,27].
The dietary TAC and antioxidant intake for each participant were calculated using the TAC database, following the same method used to calculate nutrient intake. To better reflect long-term dietary consumption and reduce measurement errors [28], we calculated the cumulative averages of dTAC and antioxidant intake. This was achieved by averaging the intakes at baseline and during subsequent repeated examinations until each participant reached their endpoint or was censored. A maximum of 3 FFQs per person (average, 1.84), conducted at baseline and during follow-up visits, were utilized to calculate dTAC and antioxidants intake. All analyses employed the cumulative average of dTAC (mg VCE/day) and antioxidant intake (mg/day).
Assessment of covariates
The interviewers and examiners of the 3 cohorts received training from trainers at the quality control center. To overcome the limitations inherent in a multicenter study, data collection strictly adhered to standard protocols for questionnaire surveys and examinations. Trained interviewers used a structured questionnaire to gather data on demographic characteristics such as age and education, as well as established risk factors for MetS, including regular exercise, smoking status, and current alcohol consumption. Daily alcohol consumption (in g/day) was calculated by multiplying the average frequency of consumption for 6 types of alcoholic beverages (soju, takju, beer, refined rice wine, wine, and whisky; in times/day) by the quantity consumed per occasion. This calculation considered the alcohol content (%) of each beverage and the specific gravity of alcohol (0.79). Height measurements were taken to the nearest 0.1 cm using a stadiometer, while weight was measured to the nearest 0.1 kg on a metric scale. These measurements were taken with participants dressed in light clothing and without shoes. BMI was then calculated as the ratio of weight (in kg) to the square of height (in m2). Participants were categorized into 2 groups based on obesity status: those with BMI < 23 kg/m2 and those with BMI ≥ 23 kg/m2.
Statistical analysis
All analyses were conducted separately for men and women. The unadjusted baseline characteristics of the study population are presented as mean± standard deviation for quantitative variables and as numbers and percentages for categorical variables. Age-adjusted characteristics are presented as mean± standard error for quantitative variables and as percentages for categorical variables. We employed the general linear model to determine age-adjusted differences in baseline characteristics based on the quartiles (Q) of the cumulative averages of dTAC and antioxidants, using the lowest quartile (Q1) as the reference category. Tukey post-hoc tests were used to identify group differences at a significance level of p < 0.05. We used a modified Poisson regression model to estimate the incidence rate ratios (IRRs) and 95% confidence intervals (CIs) with a robust error estimator [29]. Three models were presented to adjust for potential confounders: (1) a model adjusted for age (in years); (2) multivariable model 1, which was additionally adjusted for potential confounders of MetS [30] such as higher education level (≥ 12 years of schooling, yes or no), regular exercise (≥3 times/wk and ≥30 min/session, yes or no), smoking status (current/past/never-smokers for men and current/non-smokers for women), current drinking status (yes or no), BMI (kg/m2), and total energy intake (kcal/day); and (3) multivariable model 2, which incorporated dietary factors previously reported to be associated with MetS [31], including the glycemic index (GI) and intake of calcium (mg/day), fiber (g/day), magnesium (mg/day), and sodium (mg/day) into multivariable model 1. A linear trend was obtained by treating the median value of each category of dTAC and antioxidant intake as a continuous value. We also examined the non-linear relationship of dTAC and individual antioxidant intake with the risk of MetS. Tests for non-linearity incorporated the Wald test to compare the deviance of the linear trend model to the deviance of the categorical model [32]. Restricted cubic spline analyses with 3 knots (at the 25th, 50th, and 75th percentiles) were conducted to explore possible non-linear associations. The models were adjusted for the same potential confounders as those in the final Poisson regression model. The results of these analyses are presented in Supplementary Materials 1 and 2. The association of each exposure variable with the MetS risk was analyzed by obesity status group. The potential interaction was assessed by adding the cross-product term of the exposure categories and gender or BMI group.
The final models confirmed the absence of multicollinearity in the variance inflation factor (VIF< 10), ensuring no multicollinearity among the independent variables [33]. We performed several sensitivity analyses to assess the robustness of our findings. First, we censored participants with a reported diagnosis of CVD or cancer (494 participants) between visits. This was done to minimize the potential influence of their treatments on MetS. Second, we conducted a sensitivity analysis that excluded any antioxidant supplement users of any antioxidant used when calculating the TAC (8.93%). Third, after selecting the major food sources that contributed 10% or more to the intake (%) or variation (r2) of dTAC and each antioxidant, we investigated the association of dTAC and antioxidants (classes and flavonoid subclasses) from those food sources with the risk of MetS incidence.
All statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) and R version 4.0.0 (R Foundation for Statistical Computing, Vienna, Austria). A p-value of less than 0.05 was considered to indicate statistical significance.
Ethics statement
The study was conducted in accordance with the principles of the Declaration of Helsinki, and the study protocol was approved by the Institutional Review Board of Hanyang University (HYU-2020-04-003-1). All participants provided written informed consent before participating in the study.
A total of 2,416 de novo cases (930 men and 1,486 women) were recorded over 58,750 person-years (23,132 for men and 35,618 for women). The median follow-up period was 5.16 years (interquartile range, 1.97 to 7.86). The mean ages of the men and women were 59.7 years and 56.3 years, respectively (Supplemental Material 3). The cumulative average values of dTAC were 269 mg VCE/day for men and 316 mg VCE/day for women. Flavonoids made up 82% of the total dTAC, followed by vitamin C at 16.6%, carotenoids at 0.92%, and then vitamin E and retinol. Table 1 presents the age-adjusted characteristics of the study participants by dTAC quartile. Participants in the highest quartile (Q4) for dTAC tended to be relatively highly educated, never-smokers, and regular exercisers; additionally, they had a higher BMI and intake of total energy, calcium, fiber, magnesium, and sodium, along with a lower GI. Similar trends were also observed in Q4 of the antioxidant classes and flavonoid subclasses (data not shown).
Tables 2 and 3 present the associations of dTAC, the 5 antioxidant classes, and the 7 flavonoid subclasses with MetS incidence. After adjusting for covariates, including dietary factors, dietary TAC demonstrated an L-shaped association with the risk of MetS in men, although no significant association was observed in Q4. However, no significant association was found between dTAC and MetS in women. The intake levels of the following antioxidant classes were inversely associated with MetS incidence in both men and women, presented with IRR and 95% CI values for Q4 versus Q1: retinol (men: IRR, 0.65; 95% CI, 0.49 to 0.85; women: IRR, 0.72, 95% CI, 0.57 to 0.91), vitamin C (men: IRR, 0.56; 95% CI, 0.42 to 0.75; women: IRR, 0.69; 95% CI, 0.55 to 0.88), vitamin E (men: IRR, 0.76; 95% CI, 0.57 to 1.00; women: IRR, 0.75; 95% CI, 0.60 to 0.94), and carotenoids (men: IRR, 0.58; 95% CI, 0.46 to 0.74; women: IRR, 0.74; 95% CI, 0.60 to 0.91). Among the 5 antioxidant classes, total flavonoid intake was not significantly associated with the risk of MetS in women, unlike in men (IRR, 0.69; 95% CI, 0.54 to 0.88). However, an inverse trend was observed for the 7 subclasses of flavonoids, with the exception of flavones in men and flavan-3-ols in women (Table 3). Significant non-linear associations, possibly U-shaped or L-shaped, were found for all significant inverse associations (Supplemental Materials 1 and 2), although some significant linear relationships with the risk of MetS were also observed (plinearity< 0.001 for carotenoids in men, plinearity < 0.001 for anthocyanin in men, plinearity< 0.001 for proanthocyanidins in men, and plinearity< 0.001 for flavonols in women based on the Bonferroni criteria of multiplicity [p< 0.05/26= 0.002]). For all associations between intake of antioxidants and MetS risk, no significant differences were observed between genders (all pinter≥ 0.05; data not shown).
In the sensitivity analyses, the inverse associations remained robust even after censoring CVD and cancers that developed during the follow-up period (494 participants) (Supplemental Material 4) and excluding supplement users of any antioxidants used to calculate dTAC (Supplemental Material 5). Dietary TAC and each antioxidant from most major food sources continued to show inverse associations with the risk of MetS incidence in both men and women. The exceptions were isoflavones from fermented soy products, which exhibited a null association, and vitamin C and flavones from Baechu-kimchi, which showed a positive association, but only in Q4 (Supplemental Material 6).
Figure 1 presents the associations of dTAC, antioxidant classes, and flavonoid subclasses with the risk of MetS, stratified by BMI group (overweight/obese vs. underweight/normal weight). The inverse associations persisted in participants who were overweight or obese compared to those of normal weight. However, a significant interaction was observed only for proanthocyanidins in women (pinter= 0.025), and this did not meet the significance threshold based on the Bonferroni criteria.
We observed a weak association between the average dTAC and MetS in men, but no association in women. However, we found that the average intake of antioxidants, apart from total flavonoids in women, was inversely associated with the risk of MetS. Among the 7 subclasses of flavonoids, most were inversely associated with the risk of MetS in both men and women (Q4 vs. Q1), except for flavones in men and flavan-3-ols in women. These trends were characterized by non-linear, L-shaped relationships. We did not observe any gender-based interactions, and the beneficial associations for MetS were primarily seen in men and women who were relatively obese.
In this study, the average dTAC was 279.5 mg VCE/day; this is lower than the 384.7 mg VCE/day value reported for Korean adults aged 19 years and older, based on 24-hour recall data from the Korean National Health and Nutrition Examination Survey (KNHANES) [34]. However, relative to the dTAC values in the United States population (217.6 mg VCE/day for supplement non-users and 268.4 mg VCE/day for antioxidant supplement users) [35], the dTAC values observed in our study were high. The discrepancy in dTAC values, with the present finding being lower than the KNHANES but higher than the United States population measurement, could be attributed to several factors: (1) the use of different dietary assessment methods (FFQ in the present study versus 24-hour recall in the KNHANES), (2) the age group considered (≥ 40 years in the present study vs. ≥ 19 years in the KNHANES), and (3) variations in dietary pattern (a high intake of plant-based foods rich in flavonoids, including vegetables and legumes, in this study relative to the United States population) [36].
In the present study, the major food sources of dTAC and each antioxidant were as follows. Green tea (dTAC and total flavonoids), milk (retinol), and tomato/tomato juice (carotenoids) explained more than 50% of the variation in dietary intake. For the 7 flavonoids, orange/orange juice (flavanones), green tea (flavan-3-ols), grapes/grape juice (anthocyanins), and apples/apple juice (proanthocyanidins) contributed to over 50% of the variation in dietary intake (Supplemental Material 6). Depending on dietary patterns and food availability, the type and amount of antioxidants contributing to dTAC may vary across regions and countries [36]. However, the primary food sources of dTAC and antioxidants were sufficiently similar across studies, with fruits, vegetables, legumes, and beverages such as tea, wine, and juice being the main contributors [36].
In this study, we observed an L-shaped association between dTAC and the risk of MetS in men, although this was not significant for Q4. Moreover, as previously reported, no such association was present in women (pinter≥ 0.05) [12]. However, as recent crosssectional studies [37,38] and a prospective cohort study (the Tehran Lipid and Glucose Study) [39] have reported inverse associations of dTAC with MetS and its components, we conducted additional analyses on food sources to explore the potential for a weak or no association of dTAC in this study. First, we considered green tea, a primary food source of dTAC for both men and women. We found a significant L-shaped association for both genders. Second, we examined Baechu-kimchi consumption, as the vitamin C and flavones in this food showed positive associations with the risk of MetS in this study. When we adjusted for Baechu-kimchi consumption, a significant association was found even in Q4 of dTAC in men. After stratifying the Baechu-kimchi consumption by the median value, an inverse association was observed only in women with low Baechu-kimchi consumption (data not shown, pinter= 0.049). Notably, Baechu-kimchi is a major contributor of dietary salt in Korea, and the present study included a high proportion (70.8%) of postmenopausal women, who are known to be more sensitive to salt than premenopausal women [40]. Thus, it is possible that the protective effects of dTAC were insufficient to counteract the adverse effects of salt on cardiometabolic risks, particularly BP. Additionally, China and Poland, where studies have reported an inverse association between dTAC and MetS, exhibit lower salt intakes compared to Korea [41]. This suggests that the weak or absent association between dTAC and MetS in the present study may be partially due to the relatively high salt intake, which can lead to salt-dependent oxidative stress by eliminating the local nitric oxide activity and increasing microvascular levels of reactive oxygen species [42].
We observed an inverse association between total flavonoid consumption and MetS risk in men but not in women, with no significant gender-based specificity. Total flavonoids were the largest contributor to dTAC in the present study (mg VCE/d, 82.2% in men and 81.6% in women) and in representative Koreans from the KNHANES [34]. Total flavonoids were also found to be inversely associated with MetS risk in urban Polish cross-sectional [37] and Chinese prospective [43] studies. This association was observed for total flavonoids and flavanols (a combination of flavan-3-ol monomers and flavanol-derived compounds) in the Polish cross-sectional study [37] and for total flavonoid intake in the Chinese prospective study [43]. On the contrary, a cross-sectional Korean study showed no association of flavonoids with the prevalence risk of MetS [38]. Nevertheless, we found that intake of green tea, apples/apple juice, and grapes/grape juice, which were the major sources of flavonoids in this study, was inversely associated with the MetS risk, even in women (Supplemental Material 6). Like the association observed for dTAC in the stratification analysis of Baechu-kimchi consumption, total flavonoid intake was significantly and inversely associated with the MetS risk only in women with low Baechu-kimchi consumption (data not shown). Based on these findings, it is likely that flavonoids have a beneficial effect on reducing the risk of MetS.
Among flavonoid subclasses, flavones in men and flavan-3-ols in women were not significantly associated with MetS in Q4 in the present study. As we mentioned above, a major food source of flavones (Baechu-kimchi) was the only major source of antioxidants to exhibit a positive association with MetS. As for flavan3-ols, green tea, a major food source, appeared to have an inverse association with MetS; however, we could not explain why MetS was not associated with flavan-3-ol intake in women. That said, the inverse associations of 4 antioxidant vitamins (e.g., vitamin C, vitamin E, and carotenoids) with MetS risk were consistent with previous observational studies [44-46]. This could be explained by the direct effect of oxidative stress in the pathogenesis of MetS [4] and by the beneficial effect of antioxidant treatment on MetS components.
Most antioxidant classes and flavonoid subclasses displayed non-linear rather than linear associations, which was observed from a relatively low intake level (primarily Q2). Unfortunately, we were unable to establish a precise threshold for dietary antioxidant intake to prevent the onset of MetS; this was due to our method of collecting dietary data, which involved calculating relative intake from FFQ. However, the non-linearity was similar to that observed in a previous study on the association between antioxidant compounds, including flavonoids, and CVD risk [47]. This suggests that the trend may plateau, with no additional benefits beyond a certain intake level. Despite this, the dose-response relationship between dietary antioxidants and diseases, including MetS, remains ambiguous [4,7]. Further research is needed to establish reasonable standards or critical daily antioxidant intake doses. Furthermore, our findings indicate that these antioxidants are more effective in preventing MetS in overweight or obese individuals than in those who are underweight or of normal weight. Alongside growing evidence supporting the anti-obesity effects of antioxidants [48], these results suggest that the associations of dTAC, antioxidant classes, and flavonoid subclasses with MetS could be modified by baseline obesity status.
Several limitations should be considered when interpreting our results. First, our validated food-based FFQ was not specifically designed to assess antioxidants and dTAC, and it omitted a substantial portion of cooking oil and seasonings. Secondly, no universally accepted method is available to measure the antioxidant capacity of food, so values should be compared and interpreted with caution. Third, some measurement errors are unavoidable in dietary assessment using FFQ. The precise assessment of dietary intake and the large variability in antioxidant intake between different populations or nations present potential challenges in understanding the various functions of dTAC, antioxidant classes, and flavonoid subclasses [36]. Therefore, even though we used cumulative average intake to minimize random measurement errors, the accuracy of the antioxidant database must be enhanced. Fourth, our findings suggested that the inverse associations of antioxidant classes and flavonoid subclasses with MetS were more evident than those with dTAC. This implies that dTAC may not reflect the overall antioxidant capacity in the human body, which is influenced by a variety of endogenous and exogenous mechanisms [49]. Thus, although we used a validated algorithm to estimate dTAC [8], the algorithm should be refined by considering various factors that influence the antioxidant capacity of each food, such as cooking methods and added seasonings like salt. Finally, our analysis accounted for known confounding variables, such as total energy intake, glycemic index, calcium, fiber, magnesium, and sodium. However, other unmeasured confounding factors may exist. Furthermore, the current study did not include dyslipidemia medication in the definition of MetS, which could have led to the misclassification of participants taking dyslipidemia medication but with normal levels of TG or HDL-C. To address this limitation, we adjusted for dyslipidemia medications, and our findings remained robust. Despite these limitations, the present study exemplified a prospective design using repeated dietary assessment data and analyzed dTAC using a validated algorithm, subclass intake, and source foods.
In conclusion, the findings of this prospective study suggest that, with the exception of dTAC (Q4) and flavones (Q4) in men and dTAC, total flavonoids, and flavan-3-ol in women, 5 classes of antioxidants and 7 subclasses of flavonoids may help reduce the risk of developing MetS, especially in obese individuals. Moreover, after adjusting for or stratifying by the traditional Korean food, Baechu-kimchi, we noted a more pronounced inverse relationship of dTAC and total flavonoids with the risk of MetS. Therefore, future research should employ innovative methods to account for the complexity of food to reflect dietary cultures, such as cooking methods and the interplay between food and nutrient intake.
Supplementary materials are available at https://www.e-epih.org/.

Supplementary Material 1.

1.1. Nonlinear dose-response association of dTAC and antioxidants with incident MetS in men: a restricted cubic spline analysis with three knots (located at the 25th, 50th, and 75th percentiles)
1.2. Nonlinear dose-response association of dTAC and antioxidant classes with incident MetS in women: a restricted cubic spline analysis with three knots (located at the 25th, 50th, and 75th percentiles)
epih-45-e2023067-Supplementary-1.docx

Supplementary Material 2

2.1. Nonlinear dose-response association of total flavonoids and flavonoid subclasses with incident MetS in men: a restricted cubic spline analysis with three knots (located at the 25th, 50th, and 75th percentiles)
2.2. Nonlinear dose-response association of total flavonoids and flavonoid subclasses with incident MetS in women: a restricted cubic spline analysis with three knots (located at the 25th, 50th, and 75th percentiles)
epih-45-e2023067-Supplementary-2.docx

Supplementary Material 3

Baseline characteristics of the study participants (n=11,379)
epih-45-e2023067-Supplementary-3.docx

Supplementary Material 4

Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) of MetS by the quartiles of dTAC and antioxidant classes after censoring CVD and cancer (n=11,379)
epih-45-e2023067-Supplementary-4.docx

Supplementary Material 5

Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) of MetS by quartiles of dTAC and antioxidant classes among only non-users of antioxidant component supplement (n=8,786)
epih-45-e2023067-Supplementary-5.docx

Supplementary Material 6

Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) of MetS by quartiles of dTAC and antioxidant classes of their major food sources (n=11,379)
epih-45-e2023067-Supplementary-6.docx

CONFLICT OF INTEREST

The authors have no conflicts of interest to declare for this study.

FUNDING

This work was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (2004-E71004-00, 2005-E71011-00, 2006-E71009-00, 2007-E71002-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00, 2011-E71002-00, 2012-E71007-00, 2013-E71008-00, 2014-E71006-00, 2014-E71006-01, 2016-E71001-00, 2017N-E71001-00) and by a National Research Foundation of Korea (NRF) grant funded by the government (MSIT) (No. NRF-2020R1A2C1004815).

AUTHOR CONTRIBUTIONS

Conceptualization: Kong JS, Kim MK. Data curation: Kong JS, Lee J, Kim Y, Woo HW. Formal analysis: Kong JS. Funding acquisition: Kim YM, Shin MH, Koh SB, Kim HC, Kim MK. Methodology: Kong JS, Kim MK. Project administration: Kim MK. Visualization: Kong JS. Writing – original draft: Kong JS, Kim MK. Writing – review & editing: Kong JS, Lee J, Kim Y, Woo HW, Kim YM, Shin MH, Koh SB, Kim HC, Kim MK.

None.
Figure 1.
Incidence rate ratios (IRRs) of metabolic syndrome for low (quartile 1) versus high (quartile 4) intake levels by BMI group (A) men, and (B) women. dTAC, dietary total antioxidant capacity; BMI, body mass index. 1The p-interaction was tested by adding the cross-product term of the exposure categories and BMI group. The multivariable model was adjusted for age (years), higher education level (≥12 years), regular exercise (≥3 times/wk for ≥30 min/session), smoking status (current/past/never-smokers for men and current/non-smokers for women), drinking status (yes or no), BMI (kg/m2), total energy intake, glycemic index, calcium (mg/day), fiber (g/day), magnesium (mg/day), and sodium (mg/day) in men and women.
epih-45-e2023067f1.jpg
epih-45-e2023067f2.jpg
Table 1.
Age-adjusted characteristics of study participants by quartile of dTAC
Characteristics Men (n=4,422)
 p diff1 p trend2 Women (n=6,957)
 p diff1 p trend2
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Total (n) 1,105 1,106 1,106 1,105 1,739 1,739 1,740 1,739
Median (Min-Max) of dTAC (mg VCE/day) 76.5 (6.1-109.4) 142.4 (109.4-183.7) 232.3 (183.0-325.8) 505.8 (325.0-4,537.5) 84.6 (2.0-123.5) 162.8 (124.5-210.4) 276.1 (210.4-381.2) 607.2 (381.2-5,056.3)
Age (yr) 62.6±10.0a 60.7±9.3b 59.1±9.4c 56.3±9.1d <0.001 <0.001 61.2±10.4a 57.4±9.5b 54.3±8.7c 52.1±8.1d <0.001 <0.001
Higher education3 25.4 31.5 38.7 46.2 <0.001 <0.001 20.5 23.6 30.3 36.6 <0.001 <0.001
Regular exercise4 13.0 17.2 23.2 29.9 <0.001 <0.001 14.3 19.4 26.2 33.1 <0.001 <0.001
Smoking status
Never-smoker 26.4 26.3 31.2 32.5 0.001 <0.001 94.5 97.2 97.2 95.3 <0.001 0.533
Past smoker 31.5 33.7 32.8 38.4 0.005 0.001 1.2 0.8 0.9 1.6 0.092 0.079
Current smoker 42.1 40.1 36.1 29.2 <0.001 <0.001 4.3 2.0 1.9 3.1 <0.001 0.695
Current drinker 64.0 64.5 62.3 67.3 0.112 0.084 28.4 29.4 29.4 32.7 0.047 0.006
Alcohol consumption (g/day) 23.1±1.3 20.7±1.3 21.2±1.3 22.0±1.3 0.575 0.905 1.8±0.2 1.8±0.2 1.8±0.2 2.4±0.2 0.106 0.021
Body mass index (kg/m2) 22.9±0.1a 23.1±0.1a 23.1±0.1a 23.5±0.1b <0.001 <0.001 23.3±0.1a 23.5±0.1a 23.6±0.1a,b 23.8±0.1b <0.001 <0.001
Dietary factors5
Total energy intake (kcal/day) 1,398.2±11.5a 1,589.3±11.4b 1,801.3±11.4c 1,902.1±11.5d <0.001 <0.001 1,242.2±9.2a 1,448.2±8.9b 1,591.5±8.9c 1,745.3±9.1d <0.001 <0.001
Glycemic index 58.5±0.1a 57.5±0.1b 56.9±0.1c 56.3±0.1d <0.001 <0.001 58.8±0.1a 57.7±0.1b 56.6±0.1c 55.5±0.1d <0.001 <0.001
Calcium (mg/day) 274.6±3.9a 333.4±3.9b 369.5±3.9c 405.7±3.9d <0.001 <0.001 274.1±3.5a 328.5±3.4b 370.0±3.4c 421.0±3.4d <0.001 <0.001
Fiber (g/day) 12.8±0.1a 15.3±0.1b 16.4±0.1c 17.6±0.1d <0.001 <0.001 11.8±0.1a 14.2±0.1b 15.9±0.1c 17.2±0.1d <0.001 <0.001
Magnesium (mg/day) 92.9±0.5a 93.8±0.5a 95.6±0.5b 98.4±0.6c <0.001 <0.001 83.6±0.4a 84.3±0.4a 86.9±0.4b 92.1±0.4c <0.001 <0.001
Sodium (mg/day) 2,487.2±41.9a 2,885.8±41.4b 2,975.8±41.4a 3,128.1±42.0c <0.001 <0.001 2,033.3±30.7a 2,362.8±29.7b 2,488.1±29.8c 2,648.0±30.4d <0.001 <0.001

Values are presented as mean±standard error for continuous variables and % for categorical variables; Mean values with different superscripts (a, b, c) within a row exhibited significant differences among the exposure groups on the Tukey multiple comparison test.

dTAC, dietary total antioxidant capacity; VCE, vitamin C equivalent; Q, quartile; Min, minimum; Max, maximum.

1 Using the general linear model (Tukey multiple comparison).

2 Linear trends were obtained by treating the median value of each group as a continuous variable.

3 Higher education level (≥12 years of schooling).

4 Regular exercise (≥3 times/wk and ≥30 min/session).

5 Nutrient intakes were adjusted for total energy intake using the residual method.

Table 2.
Incidence rate ratios and 95% confidence intervals of MetS by quartile of dTAC and intake of 5 antioxidant classes (n=11,379)
Model1 Men (n=4,422)
 plinearity2 pnon-linearity3 Women (n=6,957)
 plinearity2 pnon-linearity3
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
dTAC (mg VCE/day)
Median (Min-Max) 76.5 (6.1-109.4) 142.4 (109.4-182.7) 232.3 (183.0-324.8) 504.8 (325.0-4,537.5) 84.6 (2.0-123.5) 161.8 (123.5-210.4) 276.1 (210.4-381.2) 607.2 (381.2-5,056.3)
Cases/PY 242/5,348 216/5,996 228/5,977 244/5,811 387/8,149 387/9,068 372/9,280 340/9,122
Age-adjusted model 1.00 (reference) 0.80 (0.67, 0.95) 0.84 (0.71, 1.00) 0.93 (0.77,1.11) 0.866 0.023 1.00 (reference) 1.02 (0.89, 1.17) 1.06 (0.92, 1.23) 1.07 (0.92, 1.24) 0.405 0.845
Multivariable model 1 1.00 (reference) 0.77 (0.64, 0.92) 0.81 (0.67, 0.98) 0.82 (0.67, 1.01) 0.424 0.017 1.00 (reference) 0.98 (0.85, 1.13) 0.98 (0.84, 1.14) 0.91 (0.77, 1.08) 0.261 0.960
Multivariable model 2 1.00 (reference) 0.75 (0.62, 0.91) 0.79 (0.64, 0.97) 0.80 (0.63, 1.02) 0.583 0.012 1.00 (reference) 0.94 (0.81, 1.09) 0.92 (0.77, 1.09) 0.84 (0.69, 1.03) 0.110 0.872
Retinol (mg/day)
Median (Min-Max) 0.01 (0.00-0.02) 0.03 (0.02-0.05) 0.07 (0.05-0.09) 0.14 (0.09-0.74) 0.01 (0.00-0.02) 0.03 (0.02-0.05) 0.07 (0.05-0.10) 0.14 (0.10-0.87)
Cases/PY 269/5,305 220/5,841 209/6,208 232/5,778 457/7,924 360/9,187 325/9,802 344/8,705
Age-adjusted model 1.00 (reference) 0.75 (0.67, 0.83) 0.66 (0.59, 0.74) 0.80 (0.72, 0.90) 0.062 <0.001 1.00 (reference) 0.77 (0.67, 0.88) 0.69 (0.60, 0.79) 0.84 (0.73, 0.98) 0.119 <0.001
Multivariable model 1 1.00 (reference) 0.74 (0.66, 0.83) 0.65 (0.58, 0.73) 0.74 (0.65, 0.85) 0.014 0.001 1.00 (reference) 0.76 (0.66, 0.87) 0.66 (0.57, 0.77) 0.77 (0.65, 0.91) 0.016 <0.001
Multivariable model 2 1.00 (reference) 0.71 (0.59, 0.86) 0.62 (0.50, 0.76) 0.65 (0.49, 0.85) 0.021 <0.001 1.00 (reference) 0.76 (0.66, 0.87) 0.65 (0.55, 0.77) 0.72 (0.57, 0.91) 0.029 <0.001
Vitamin C (mg/day)
Median (Min-Max) 18.6 (1.4-25.0) 30.8 (25.0-37.1) 44.7 (37.1-54.8) 72.0 (54.9-432.7) 20.5 (0.5-28.6) 36.6 (28.6-44.7) 54.3 (44.7-66.7) 88.9 (66.7-391.2)
Cases/PY 252/5,334 221/5,994 229/6,111 228/5,693 405/8,090 373/9,291 357/9,192 351/9,045
Age-adjusted model 1.00 (reference) 0.78 (0.65, 0.93) 0.79 (0.66, 0.94) 0.84 (0.71, 1.01) 0.215 0.017 1.00 (reference) 0.90 (0.78, 1.03) 0.97 (0.83, 1.12) 1.01 (0.87, 1.17) 0.550 0.227
Multivariable model 1 1.00 (reference) 0.72 (0.60, 0.86) 0.69 (0.57, 0.83) 0.70 (0.57, 0.87) 0.011 0.002 1.00 (reference) 0.85 (0.74, 0.98) 0.89 (0.76, 1.04) 0.87 (0.73, 1.04) 0.295 0.125
Multivariable model 2 1.00 (reference) 0.66 (0.54, 0.79) 0.59 (0.48, 0.74) 0.56 (0.42, 0.75) 0.002 <0.001 1.00 (reference) 0.79 (0.68, 0.91) 0.78 (0.65, 0.93) 0.69 (0.55, 0.88) 0.011 0.057
Vitamin E (mg/day)
Median (Min-Max) 2.0 (0.0- 2.8) 3.5 (2.8-4.3) 5.2 (4.3-6.3) 8.2 (6.3-27.6) 1.6 (0.0-2.4) 3.1 (2.4-3.9) 4.8 (3.9-6.0) 7.9 (6.0-36.9)
Cases/PY 250/5,286 225/6,041 214/6,205 241/5,600 431/8,164 376/9,263 326/9,418 353/8,773
Age-adjusted model 1.00 (reference) 0.79 (0.66, 0.93) 0.73 (0.61, 0.87) 0.91 (0.76, 1.08) 0.514 0.001 1.00 (reference) 0.88 (0.77, 1.01) 0.79 (0.68, 0.92) 0.97 (0.84, 1.13) 0.830 0.002
Multivariable model 1 1.00 (reference) 0.74 (0.62, 0.89) 0.65 (0.53, 0.79) 0.76 (0.60, 0.97) 0.087 <0.001 1.00 (reference) 0.84 (0.73, 0.97) 0.74 (0.63, 0.86) 0.86 (0.71, 1.03) 0.121 0.001
Multivariable model 2 1.00 (reference) 0.74 (0.61, 0.89) 0.65 (0.52, 0.80) 0.76 (0.57, 1.00) 0.183 <0.001 1.00 (reference) 0.81 (0.70, 0.94) 0.69 (0.58, 0.82) 0.75 (0.60, 0.94) 0.026 0.001
Carotenoids (mg/day)
Median (Min-Max) 2.1 (0.0-3.1) 4.0 (3.1-5.0) 6.2 (5.0-8.0) 11.0 (8.0-119.3) 2.3 (0.0-3.5) 4.7 (3.5-5.9) 7.3 (5.9-9.3) 12.8 (9.3-120.3)
Cases/PY 266/5,286 210/5,979 223/6,115 231/5,752 396/8,009 390/9,140 338/9,376 362/9,093
Age-adjusted model 1.00 (reference) 0.70 (0.59, 0.83) 0.72 (0.61, 0.86) 0.80 (0.67, 0.95) 0.127 <0.001 1.00 (reference) 0.94 (0.82, 1.08) 0.86 (0.74, 1.00) 0.99 (0.85, 1.15) 0.978 0.073
Multivariable model 1 1.00 (reference) 0.65 (0.55, 0.78) 0.63 (0.53, 0.76) 0.66 (0.54, 0.81) 0.003 <0.001 1.00 (reference) 0.92 (0.80, 1.06) 0.81 (0.69, 0.94) 0.87 (0.74, 1.03) 0.125 0.059
Multivariable model 2 1.00 (reference) 0.62 (0.52, 0.74) 0.58 (0.48, 0.71) 0.58 (0.46, 0.74) 0.001 <0.001 1.00 (reference) 0.87 (0.76, 1.01) 0.73 (0.62, 0.87) 0.74 (0.60, 0.91) 0.006 0.040
Flavonoids (mg/day)
Median (Min-Max) 44.8 (2.2-66.0) 87.4 (66.0-111.9) 144.9 (112.1-193.5) 293.7 (193.6-1,982.4) 50.5 (0.7-75.6) 101.8 (75.6-134.6) 177.1 (134.7-239.8) 350.6 (239.8-2,484.9)
Cases/PY 255/5,264 211/6,012 230/6,039 234/5,817 392/8,029 380/9,202 373/9,444 341/8,943
Age-adjusted model 1.00 (reference) 0.72 (0.61, 0.86) 0.78 (0.66, 0.93) 0.83 (0.69, 0.99) 0.351 0.001 1.00 (reference) 0.98 (0.85, 1.12) 1.02 (0.88, 1.18) 1.06 (0.91, 1.24) <0.001 0.869
Multivariable model 1 1.00 (reference) 0.70 (0.58, 0.83) 0.72 (0.60, 0.87) 0.72 (0.58, 0.88) 0.183 0.001 1.00 (reference) 0.96 (0.83, 1.11) 0.95 (0.81, 1.11) 0.94 (0.79, 1.12) 0.121 0.868
Multivariable model 2 1.00 (reference) 0.68 (0.56, 0.82) 0.70 (0.58, 0.86) 0.69 (0.54, 0.88) 0.118 <0.001 1.00 (reference) 0.94 (0.81, 1.09) 0.92 (0.78, 1.09) 0.90 (0.74, 1.11) 0.435 0.764

MetS, metabolic syndrome; VCE, vitamin C equivalents; dTAC, dietary total antioxidant capacity; Q, quartile; Min, minimum; Max, maximum; PY, person-year.

1 Multivariable model 1 was adjusted for age (years), higher education level (≥12 years of schooling), regular exercise (≥3 times/wk and ≥30 min/session), smoking status (current/past/never-smokers for men and current/non-smokers for women), drinking status (yes or no), body mass index (kg/m2), and total energy intake (kcal/day) in men and women.

Multivariable model 2 was adjusted for glycemic index, calcium (mg/day), fiber (g/day), magnesium (mg/day), sodium (mg/day), and all covariates in multivariable model 1.

2 Linear trends were obtained by treating the median value of each group as a continuous variable.

3 Non-linear trends were obtained by comparing the deviance difference between the linear trend model with 1 degree of freedom and the ℓ ordered categorical model with ℓ−1 degrees of freedom.

Table 3.
Incidence rate ratios and 95% confidence intervals of MetS by quartile of intake of 7 flavonoid subclasses (n=11,379)
Model1 Men (n=4,422)
 plinearity2 pnon-linearity3 Women (n=6,957)
 plinearity2 pnon-linearity3
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Flavonols (mg/day)
Median (Min- Max) 6.8 (0.2-9.4) 11.9 (9.4-14.5) 17.7 (14.6- 22.1) 29.3 (22.1-245.7) 6.3 (0.0-9.0) 11.5 (9.0-14.5) 17.7 (14.5-22.8) 31.8 (22.8-219.2)
Cases/PY 240/5,296 202/6,131 247/6,139 241/5,566 415/8,042 392/9,258 321/9,570 358/8,748
Age-adjusted model 1.00 (reference) 0.73 (0.61, 0.87) 0.89 (0.75, 1.06) 0.95 (0.80, 1.14) 0.520 0.001 1.00 (reference) 0.93 (0.81, 1.06) 0.79 (0.68, 0.91) 1.01 (0.87, 1.17) 0.720 0.001
Multivariable model 1 1.00 (reference) 0.69 (0.57, 0.82) 0.78 (0.64, 0.93) 0.78 (0.64, 0.95) 0.183 0.001 1.00 (reference) 0.88 (0.76, 1.01) 0.71 (0.61, 0.82) 0.85 (0.73, 1.01) 0.121 <0.001
Multivariable model 2 1.00 (reference) 0.65 (0.54, 0.78) 0.69 (0.56, 0.85) 0.63 (0.48, 0.82) 0.019 <0.001 1.00 (reference) 0.81 (0.70, 0.93) 0.60 (0.51, 0.71) 0.63 (0.50, 0.78) <0.001 <0.001
Flavones (mg/day)
Median (Min-Max) 0.7 (0.0-0.9) 1.2 (0.9-1.4) 1.7 (1.4-2.1) 2.7 (2.1-12.6) 0.7 (0.0-1.0) 1.3 (1.0-1.6) 1.9 (1.6-2.4) 3.3 (2.4-14.9)
Cases/PY 221/5,424 236/6,018 221/6,148 252/5,542 419/8,125 367/9,155 337/9,526 363/8,812
Age-adjusted model 1.00 (reference) 0.96 (0.81, 1.15) 0.88 (0.74, 1.06) 1.12 (0.94, 1.34) 0.174 0.079 1.00 (reference) 0.89 (0.77, 1.02) 0.84 (0.73, 0.98) 1.05 (0.90, 1.22) 0.316 0.006
Multivariable model 1 1.00 (reference) 0.88 (0.74, 1.06) 0.79 (0.65, 0.96) 0.95 (0.77, 1.17) 0.818 0.030 1.00 (reference) 0.83 (0.72, 0.96) 0.75 (0.64, 0.87) 0.88 (0.74, 1.04) 0.300 0.001
Multivariable model 2 1.00 (reference) 0.85 (0.71, 1.03) 0.75 (0.61, 0.93) 0.88 (0.67, 1.15) 0.588 0.014 1.00 (reference) 0.78 (0.67, 0.90) 0.67 (0.57, 0.79) 0.72 (0.58, 0.90) 0.018 <0.001
Flavanones (mg/day)
Median (Min-Max) 0.7 (0.0-1.7) 2.8 (1.7-4.2) 5.9 (4.2, 8.5) 12.9 (8.5-137.6) 1.2 (0.0-2.8) 4.5 (2.8-6.5) 9.1 (6.6-12.8) 19.5 (12.8-192.4)
Cases/PY 279/4,884 215/6,123 213/6,277 223/5,848 434/7,537 347/9,474 372/9,389 333/9,218
Age-adjusted model 1.00 (reference) 0.61 (0.52, 0.73) 0.59 (0.50, 0.70) 0.66 (0.56, 0.79) 0.003 <0.001 1.00 (reference) 0.70 (0.61, 0.81) 0.82 (0.71, 0.94) 0.80 (0.69, 0.93) 0.134 <0.001
Multivariable model 1 1.00 (reference) 0.61 (0.51, 0.72) 0.57 (0.48, 0.68) 0.62 (0.52, 0.75) 0.001 <0.001 1.00 (reference) 0.69 (0.60, 0.79) 0.79 (0.68, 0.91) 0.75 (0.64, 0.88) 0.035 <0.001
Multivariable model 2 1.00 (reference) 0.61 (0.51, 0.73) 0.58 (0.49, 0.70) 0.64 (0.53, 0.79) 0.004 <0.001 1.00 (reference) 0.68 (0.59, 0.79) 0.78 (0.68, 0.91) 0.73 (0.62, 0.87) 0.033 <0.001
Flavan-3-ols (mg/day)
Median (Min-Max) 2.9 (0.0-5.8) 9.6 (5.8-16.1) 28.0 (16.1, 47.9) 127.7 (48.0-1,755.8) 3.4 (0.0-7.1) 11.8 (7.1-19.0) 33.9 (19.0-57.6) 139.2 (57.7-1,808.2)
Cases/PY 247/5,179 230/5,951 207/5,935 246/6,066 402/7,849 367/9,198 373/9,025 344/9,546
Age-adjusted model 1.00 (reference) 0.81 (0.68, 0.96) 0.73 (0.61, 0.87) 0.84 (0.71, 1.00) 0.682 0.002 1.00 (reference) 0.88 (0.77, 1.02) 1.00 (0.87, 1.16) 0.93 (0.80, 1.08) 0.748 0.130
Multivariable model 1 1.00 (reference) 0.82 (0.69, 0.98) 0.69 (0.57, 0.83) 0.79 (0.65, 0.95) 0.353 0.001 1.00 (reference) 0.88 (0.76, 1.02) 0.95 (0.82, 1.10) 0.86 (0.73, 1.00) 0.145 0.214
Multivariable model 2 1.00 (reference) 0.84 (0.70, 1.00) 0.70 (0.57, 0.85) 0.79 (0.65, 0.97) 0.409 0.002 1.00 (reference) 0.87 (0.76, 1.01) 0.94 (0.80, 1.10) 0.84 (0.71, 1.00) 0.130 0.190
Anthocyanins (mg/day)
Median (Min-Max) 0.8 (0.0-1.7) 2.9 (1.7-4.2) 5.9 (4.2-8.3) 13.7 (8.3-149.9) 1.2 (0.0-2.5) 4.0 (2.5-5.9) 8.2 (5.9-12.3) 19.4 (12.3-224.7)
Cases/PY 274/4,949 233/5,989 200/6,146 223/6,047 418/7,784 373/9,331 348/9,519 347/8,984
Age-adjusted model 1.00 (reference) 0.70 (0.59, 0.83) 0.58 (0.49, 0.70) 0.66 (0.56, 0.79) 0.001 <0.001 1.00 (reference) 0.83 (0.72, 0.96) 0.82 (0.71, 0.95) 0.90 (0.77, 1.04) 0.557 0.010
Multivariable model 1 1.00 (reference) 0.69 (0.58, 0.82) 0.54 (0.44, 0.65) 0.60 (0.49, 0.72) <0.001 <0.001 1.00 (reference) 0.85 (0.74, 0.98) 0.78 (0.67, 0.91) 0.85 (0.73, 1.00) 0.215 0.009
Multivariable model 2 1.00 (reference) 0.69 (0.58, 0.82) 0.54 (0.45, 0.65) 0.60 (0.49, 0.74) <0.001 <0.001 1.00 (reference) 0.84 (0.73, 0.97) 0.77 (0.66, 0.90) 0.83 (0.70, 0.99) 0.194 0.007
Isoflavones (mg/day)
Median (Min-Max) 5.8 (0.2-8.7) 11.7 (8.7-14.9) 19.5 (14.9-25.9) 37.8 (25.9-157.1) 5.8 (0.0-8.5) 11.3 (8.5-14.5) 19.3 (14.5-25.1) 35.7 (25.1-190.8)
Cases/PY 247/5,025 244/5,961 205/6,437 234/5,709 415/7,824 368/9,041 319/9,671 384/9,082
Age-adjusted model 1.00 (reference) 0.83 (0.70, 0.99) 0.65 (0.54, 0.77) 0.83 (0.70, 0.99) 0.119 <0.001 1.00 (reference) 0.83 (0.72, 0.95) 0.69 (0.60, 0.80) 0.88 (0.77, 1.01) 0.239 <0.001
Multivariable model 1 1.00 (reference) 0.78 (0.66, 0.94) 0.60 (0.49, 0.72) 0.75 (0.62, 0.91) 0.032 <0.001 1.00 (reference) 0.81 (0.70, 0.93) 0.67 (0.58, 0.78) 0.81 (0.70, 0.95) 0.055 <0.001
Multivariable model 2 1.00 (reference) 0.78 (0.65, 0.93) 0.59 (0.48, 0.72) 0.73 (0.59, 0.91) 0.044 <0.001 1.00 (reference) 0.79 (0.69, 0.91) 0.64 (0.55, 0.75) 0.75 (0.63, 0.88) 0.010 <0.001
Proanthocyanidins (mg/day)
Median (Min-Max) 10.7 (0.0-18.4) 25.7 (18.4-34.2) 45.8 (34.3-61.7) 89.6 (61.7-1,138.7) 14.7 (0.0-24.0) 34.0 (24.1-45.3) 61.6 (45.3-85.4) 126.5 (85.4-836.5)
Cases/PY 253/5,017 245/5,873 215/6,203 217/6,038 411/7,855 392/9,090 346/9,537 337/9,136
Age-adjusted model 1.00 (reference) 0.82 (0.70, 0.98) 0.68 (0.57, 0.82) 0.71 (0.59, 0.85) <0.001 0.014 1.00 (reference) 0.91 (0.80, 1.05) 0.83 (0.71, 0.95) 0.89 (0.77, 1.04) 0.207 0.075
Multivariable model 1 1.00 (reference) 0.80 (0.67, 0.95) 0.59 (0.49, 0.71) 0.60 (0.49, 0.73) <0.001 0.001 1.00 (reference) 0.87 (0.76, 1.00) 0.78 (0.67, 0.91) 0.81 (0.68, 0.95) 0.034 0.039
Multivariable model 2 1.00 (reference) 0.79 (0.66, 0.94) 0.58 (0.48, 0.70) 0.59 (0.47, 0.74) <0.001 <0.001 1.00 (reference) 0.87 (0.75, 1.00) 0.76 (0.65, 0.89) 0.77 (0.63, 0.93) 0.023 0.036

MetS, metabolic syndrome; Q, quartile; Min, minimum; Max, maximum; PY, person-year.

1 Multivariable model 1 was adjusted for age (years), higher education level (≥12 years of schooling), regular exercise (≥3 times/wk and ≥30 min/session), smoking status (current/past/never-smokers for men and current/non-smokers for women), drinking status (yes or no), body mass index (kg/m2), and total energy intake (kcal/day) in men and women.

Multivariable model 2 was adjusted for glycemic index, calcium (mg/day), fiber (g/day), magnesium (mg/day), sodium (mg/day), and all covariates in multivariable model 1.

2 Linear trends were obtained by treating the median value of each group as a continuous variable.

3 Non-linear trends were obtained by comparing the deviance difference between the linear trend model with 1 degree of freedom and the ℓ ordered categorical model with ℓ−1 degrees of freedom.

  • 1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.ArticlePubMed
  • 2. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018;20:12.ArticlePubMedPMCPDF
  • 3. Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med 2016;26:364-373.ArticlePubMed
  • 4. Gregório BM, De Souza DB, de Morais Nascimento FA, Pereira LM, Fernandes-Santos C. The potential role of antioxidants in metabolic syndrome. Curr Pharm Des 2016;22:859-869.ArticlePubMed
  • 5. Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA. Dietary total antioxidant capacity: a novel indicator of diet quality in healthy young adults. J Am Coll Nutr 2009;28:648-656.ArticlePubMed
  • 6. Pellegrini N, Vitaglione P, Granato D, Fogliano V. Twenty-five years of total antioxidant capacity measurement of foods and biological fluids: merits and limitations. J Sci Food Agric 2020;100:5064-5078.ArticlePubMedPDF
  • 7. Parohan M, Anjom-Shoae J, Nasiri M, Khodadost M, Khatibi SR, Sadeghi O. Dietary total antioxidant capacity and mortality from all causes, cardiovascular disease and cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Nutr 2019;58:2175-2189.ArticlePubMedPDF
  • 8. Floegel A, Kim DO, Chung SJ, Song WO, Fernandez ML, Bruno RS, et al. Development and validation of an algorithm to establish a total antioxidant capacity database of the US diet. Int J Food Sci Nutr 2010;61:600-623.ArticlePubMed
  • 9. Mozaffari H, Daneshzad E, Surkan PJ, Azadbakht L. Dietary total antioxidant capacity and cardiovascular disease risk factors: a systematic review of observational studies. J Am Coll Nutr 2018;37:533-545.ArticlePubMed
  • 10. Kim SA, Joung H, Shin S. Dietary pattern, dietary total antioxidant capacity, and dyslipidemia in Korean adults. Nutr J 2019;18:37.ArticlePubMedPMCPDF
  • 11. Tan LJ, Hwang SB, Jun S, Joung H, Shin S. Dietary antioxidant consumption and the risk of type 2 diabetes in South Korean adults: a prospective cohort study based on the Health Examinees study. BMJ Open 2022;12:e065073.ArticlePubMedPMC
  • 12. Rasaee S, Alizadeh M, Kheirouri S, Abdollahzad H. Does total antioxidant capacity affect the features of metabolic syndrome? A systematic review. Nutr Food Sci 2020;51:100-113.Article
  • 13. Hosseini A, Razavi BM, Banach M, Hosseinzadeh H. Quercetin and metabolic syndrome: a review. Phytother Res 2021;35:5352-5364.ArticlePubMedPDF
  • 14. Kong JS, Kim YM, Woo HW, Shin MH, Koh SB, Kim HC, et al. Prospective Associations between cumulative average intake of flavonoids and hypertension risk in the CArdioVascular Disease Association Study (CAVAS). Nutrients 2023;15:1186.ArticlePubMedPMC
  • 15. Kim Y, Han BG; KoGES group. Cohort profile: the Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol 2017;46:e20.ArticlePubMed
  • 16. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007;30:8-13.ArticlePubMedPDF
  • 17. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.ArticlePubMed
  • 18. Ahn Y, Kwon E, Shim JE, Park MK, Joo Y, Kimm K, et al. Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr 2007;61:1435-1441.ArticlePubMedPDF
  • 19. Korean Nutrition Society. Food values (2009) [cited 2023 Jan 31]. Available from: https://kns.or.kr/English/Publication.asp.
  • 20. Ministry of Food and Drug Safety. Food and nutrient databases; 2020 [cited 2023 Jan 31]. Available from: https://various.foodsafetykorea.go.kr/nutrient/ (Korean).
  • 21. U.S. Department of Agriculture, Agricultural Research Service. Department of Agriculture, Agricultural Research Service. National nutrient database for standard reference, release 28 (slightly revised). [cited 2023 Jan 31]. Available from: https://www.ars.usda.gov/northeast-area/beltsville-md-bhnrc/beltsville-human-nutrition-research-center/methods-and-application-of-foodcomposition-laboratory/mafcl-site-pages/sr11-sr28/.
  • 22. Watanabe T, Kawai R. Advances in food composition tables in Japan-Standard Tables of Food Composition in Japan - 2015 - (seventh revised edition). Food Chem 2018;238:16-21.ArticlePubMed
  • 23. U.S. Department of Agriculture, Agricultural Research Service. Department of Agriculture, Agricultural Research Service. USDA database for the flavonoid content of selected foods, release 3.3. [cited 2023 Jan 31]. Available from: https://www.ars.usda.gov/nutrientdata/flav.
  • 24. U.S. Department of Agriculture, Agricultural Research Service. Department of Agriculture, Agricultural Research Service. USDA database for the isoflavone content of selected foods release 2.1. [cited 2023 Jan 31]. Available from: https://www.ars.usda.gov/ARSUserFiles/80400525/Data/isoflav/Isoflav_R2-1.pdf.
  • 25. Haytowitz D, Wu, X, Bhagwat S. USDA database for the proanthocyanidin content of selected foods, release 2.1 [cited 2023 Jan 31]. Available from: http://www.ars.usda.gov/nutrientdata/flav.
  • 26. Institut National de la Recherche Agronomique (INRA). PhenolExplorer 3.6. database on polyphenol content in food [cited 2023 Jan 31]. Available from: https://www.phenol-explorer.eu/.
  • 27. Kim DO, Lee CY. Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Crit Rev Food Sci Nutr 2004;44:253-273.ArticlePubMed
  • 28. Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999;149:531-540.ArticlePubMed
  • 29. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-706.ArticlePubMed
  • 30. Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. Nutr Rev 2017;75:307-326.ArticlePubMedPMC
  • 31. Djoussé L, Padilla H, Nelson TL, Gaziano JM, Mukamal KJ. Diet and metabolic syndrome. Endocr Metab Immune Disord Drug Targets 2010;10:124-137.ArticlePubMed
  • 32. Woodward M. Epidemiology: study design and data analysis. Boca Raton: CRC Press; 2013. p 452-459.
  • 33. Kleinbaum DG, Kupper LL, Nizam A, Rosenberg ES. Applied regression analysis and other multivariable methods. 5th ed. Boston: Cengage Learning; 2013. p 358-371.
  • 34. Jun S, Chun OK, Joung H. Estimation of dietary total antioxidant capacity of Korean adults. Eur J Nutr 2018;57:1615-1625.ArticlePubMedPDF
  • 35. Kim K, Vance TM, Chun OK. Greater total antioxidant capacity from diet and supplements is associated with a less atherogenic blood profile in U.S. adults. Nutrients 2016;8:15.ArticlePubMedPMC
  • 36. Escobar-Cévoli R, Castro-Espín C, Béraud V, Buckland G, Zamora-Ros R, Béraud G. An overview of global flavonoid intake and its food sources; 2017 [cited 2023 Jan 31]. Available from: https://www.intechopen.com/chapters/54289.
  • 37. Grosso G, Stepaniak U, Micek A, Stefler D, Bobak M, Pająk A. Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study. Eur J Nutr 2017;56:1409-1420.ArticlePubMedPMCPDF
  • 38. Kim S, Song Y, Lee JE, Jun S, Shin S, Wie GA, et al. Total antioxidant capacity from dietary supplement decreases the likelihood of having metabolic syndrome in Korean adults. Nutrients 2017;9:1055.ArticlePubMedPMC
  • 39. Bahadoran Z, Golzarand M, Mirmiran P, Shiva N, Azizi F. Dietary total antioxidant capacity and the occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran Lipid and Glucose Study. Nutr Metab (Lond) 2012;9:70.ArticlePubMedPMCPDF
  • 40. Colafella KM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol 2018;14:185-201.ArticlePubMedPDF
  • 41. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 2013;3:e003733.ArticlePubMedPMC
  • 42. Lenda DM, Boegehold MA. Effect of a high-salt diet on oxidant enzyme activity in skeletal muscle microcirculation. Am J Physiol Heart Circ Physiol 2002;282:H395-H402.ArticlePubMed
  • 43. Jin S, Liu J, Jia Y, Han T, Zhao X, Sun C, et al. The association of dietary flavonoids, magnesium and their interactions with the metabolic syndrome in Chinese adults: a prospective cohort study. Br J Nutr 2021;126:892-902.ArticlePubMed
  • 44. Zhang Y, Ding J, Guo H, Liu Z, Liu Q, Li Y, et al. Associations of dietary and circulating vitamin e level with metabolic syndrome. a meta-analysis of observational studies. Front Nutr 2021;8:783990.ArticlePubMedPMC
  • 45. Beydoun MA, Chen X, Jha K, Beydoun HA, Zonderman AB, Canas JA. Carotenoids, vitamin A, and their association with the metabolic syndrome: a systematic review and meta-analysis. Nutr Rev 2019;77:32-45.ArticlePubMedPMC
  • 46. Guo H, Ding J, Liu Q, Li Y, Liang J, Zhang Y. Vitamin C and metabolic syndrome: a meta-analysis of observational studies. Front Nutr 2021;8:728880.ArticlePubMedPMC
  • 47. Parmenter BH, Croft KD, Hodgson JM, Dalgaard F, Bondonno CP, Lewis JR, et al. An overview and update on the epidemiology of flavonoid intake and cardiovascular disease risk. Food Funct 2020;11:6777-6806.ArticlePubMed
  • 48. García-Barrado MJ, Iglesias-Osma MC, Pérez-García E, Carrero S, Blanco EJ, Carretero-Hernández M, et al. Role of flavonoids in the interactions among obesity, inflammation, and autophagy. Pharmaceuticals (Basel) 2020;13:342.ArticlePubMedPMC
  • 49. Grosso G, Godos J, Currenti W, Micek A, Falzone L, Libra M, et al. The effect of dietary polyphenols on vascular health and hypertension: current evidence and mechanisms of action. Nutrients 2022;14:545.ArticlePubMedPMC

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • The association of dietary total flavonoids and their subclasses with the risk of type 2 diabetes: a prospective cohort study
      Hye Won Woo, Mi Kyung Kim, Kong Ji-Sook, Jiseon Lee, Min-Ho Shin, Sang Baek Koh, Hyeon Chang Kim, Yu-Mi Kim
      European Journal of Nutrition.2024; 63(4): 1339.     CrossRef
    • A Systematized Review of the Relationship Between Obesity and Vitamin C Requirements
      Julia K Bird, Edith JM Feskens, Alida Melse-Boonstra
      Current Developments in Nutrition.2024; 8(5): 102152.     CrossRef

    Figure
    • 0
    • 1
    Related articles
    Associations of cumulative average dietary total antioxidant capacity and intake of antioxidants with metabolic syndrome risk in Korean adults aged 40 years and older: a prospective cohort study (KoGES_CAVAS)
    Image Image
    Figure 1. Incidence rate ratios (IRRs) of metabolic syndrome for low (quartile 1) versus high (quartile 4) intake levels by BMI group (A) men, and (B) women. dTAC, dietary total antioxidant capacity; BMI, body mass index. 1The p-interaction was tested by adding the cross-product term of the exposure categories and BMI group. The multivariable model was adjusted for age (years), higher education level (≥12 years), regular exercise (≥3 times/wk for ≥30 min/session), smoking status (current/past/never-smokers for men and current/non-smokers for women), drinking status (yes or no), BMI (kg/m2), total energy intake, glycemic index, calcium (mg/day), fiber (g/day), magnesium (mg/day), and sodium (mg/day) in men and women.
    Graphical abstract

    Figure 1.

    Graphical abstract

    Associations of cumulative average dietary total antioxidant capacity and intake of antioxidants with metabolic syndrome risk in Korean adults aged 40 years and older: a prospective cohort study (KoGES_CAVAS)
    Characteristics Men (n=4,422)
    		 p diff1 p trend2 Women (n=6,957)
    		 p diff1 p trend2
    Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
    Total (n) 1,105 1,106 1,106 1,105 1,739 1,739 1,740 1,739
    Median (Min-Max) of dTAC (mg VCE/day) 76.5 (6.1-109.4) 142.4 (109.4-183.7) 232.3 (183.0-325.8) 505.8 (325.0-4,537.5) 84.6 (2.0-123.5) 162.8 (124.5-210.4) 276.1 (210.4-381.2) 607.2 (381.2-5,056.3)
    Age (yr) 62.6±10.0a 60.7±9.3b 59.1±9.4c 56.3±9.1d <0.001 <0.001 61.2±10.4a 57.4±9.5b 54.3±8.7c 52.1±8.1d <0.001 <0.001
    Higher education3 25.4 31.5 38.7 46.2 <0.001 <0.001 20.5 23.6 30.3 36.6 <0.001 <0.001
    Regular exercise4 13.0 17.2 23.2 29.9 <0.001 <0.001 14.3 19.4 26.2 33.1 <0.001 <0.001
    Smoking status
    Never-smoker 26.4 26.3 31.2 32.5 0.001 <0.001 94.5 97.2 97.2 95.3 <0.001 0.533
    Past smoker 31.5 33.7 32.8 38.4 0.005 0.001 1.2 0.8 0.9 1.6 0.092 0.079
    Current smoker 42.1 40.1 36.1 29.2 <0.001 <0.001 4.3 2.0 1.9 3.1 <0.001 0.695
    Current drinker 64.0 64.5 62.3 67.3 0.112 0.084 28.4 29.4 29.4 32.7 0.047 0.006
    Alcohol consumption (g/day) 23.1±1.3 20.7±1.3 21.2±1.3 22.0±1.3 0.575 0.905 1.8±0.2 1.8±0.2 1.8±0.2 2.4±0.2 0.106 0.021
    Body mass index (kg/m2) 22.9±0.1a 23.1±0.1a 23.1±0.1a 23.5±0.1b <0.001 <0.001 23.3±0.1a 23.5±0.1a 23.6±0.1a,b 23.8±0.1b <0.001 <0.001
    Dietary factors5
    Total energy intake (kcal/day) 1,398.2±11.5a 1,589.3±11.4b 1,801.3±11.4c 1,902.1±11.5d <0.001 <0.001 1,242.2±9.2a 1,448.2±8.9b 1,591.5±8.9c 1,745.3±9.1d <0.001 <0.001
    Glycemic index 58.5±0.1a 57.5±0.1b 56.9±0.1c 56.3±0.1d <0.001 <0.001 58.8±0.1a 57.7±0.1b 56.6±0.1c 55.5±0.1d <0.001 <0.001
    Calcium (mg/day) 274.6±3.9a 333.4±3.9b 369.5±3.9c 405.7±3.9d <0.001 <0.001 274.1±3.5a 328.5±3.4b 370.0±3.4c 421.0±3.4d <0.001 <0.001
    Fiber (g/day) 12.8±0.1a 15.3±0.1b 16.4±0.1c 17.6±0.1d <0.001 <0.001 11.8±0.1a 14.2±0.1b 15.9±0.1c 17.2±0.1d <0.001 <0.001
    Magnesium (mg/day) 92.9±0.5a 93.8±0.5a 95.6±0.5b 98.4±0.6c <0.001 <0.001 83.6±0.4a 84.3±0.4a 86.9±0.4b 92.1±0.4c <0.001 <0.001
    Sodium (mg/day) 2,487.2±41.9a 2,885.8±41.4b 2,975.8±41.4a 3,128.1±42.0c <0.001 <0.001 2,033.3±30.7a 2,362.8±29.7b 2,488.1±29.8c 2,648.0±30.4d <0.001 <0.001
    Model1 Men (n=4,422)
    		 plinearity2 pnon-linearity3 Women (n=6,957)
    		 plinearity2 pnon-linearity3
    Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
    dTAC (mg VCE/day)
    Median (Min-Max) 76.5 (6.1-109.4) 142.4 (109.4-182.7) 232.3 (183.0-324.8) 504.8 (325.0-4,537.5) 84.6 (2.0-123.5) 161.8 (123.5-210.4) 276.1 (210.4-381.2) 607.2 (381.2-5,056.3)
    Cases/PY 242/5,348 216/5,996 228/5,977 244/5,811 387/8,149 387/9,068 372/9,280 340/9,122
    Age-adjusted model 1.00 (reference) 0.80 (0.67, 0.95) 0.84 (0.71, 1.00) 0.93 (0.77,1.11) 0.866 0.023 1.00 (reference) 1.02 (0.89, 1.17) 1.06 (0.92, 1.23) 1.07 (0.92, 1.24) 0.405 0.845
    Multivariable model 1 1.00 (reference) 0.77 (0.64, 0.92) 0.81 (0.67, 0.98) 0.82 (0.67, 1.01) 0.424 0.017 1.00 (reference) 0.98 (0.85, 1.13) 0.98 (0.84, 1.14) 0.91 (0.77, 1.08) 0.261 0.960
    Multivariable model 2 1.00 (reference) 0.75 (0.62, 0.91) 0.79 (0.64, 0.97) 0.80 (0.63, 1.02) 0.583 0.012 1.00 (reference) 0.94 (0.81, 1.09) 0.92 (0.77, 1.09) 0.84 (0.69, 1.03) 0.110 0.872
    Retinol (mg/day)
    Median (Min-Max) 0.01 (0.00-0.02) 0.03 (0.02-0.05) 0.07 (0.05-0.09) 0.14 (0.09-0.74) 0.01 (0.00-0.02) 0.03 (0.02-0.05) 0.07 (0.05-0.10) 0.14 (0.10-0.87)
    Cases/PY 269/5,305 220/5,841 209/6,208 232/5,778 457/7,924 360/9,187 325/9,802 344/8,705
    Age-adjusted model 1.00 (reference) 0.75 (0.67, 0.83) 0.66 (0.59, 0.74) 0.80 (0.72, 0.90) 0.062 <0.001 1.00 (reference) 0.77 (0.67, 0.88) 0.69 (0.60, 0.79) 0.84 (0.73, 0.98) 0.119 <0.001
    Multivariable model 1 1.00 (reference) 0.74 (0.66, 0.83) 0.65 (0.58, 0.73) 0.74 (0.65, 0.85) 0.014 0.001 1.00 (reference) 0.76 (0.66, 0.87) 0.66 (0.57, 0.77) 0.77 (0.65, 0.91) 0.016 <0.001
    Multivariable model 2 1.00 (reference) 0.71 (0.59, 0.86) 0.62 (0.50, 0.76) 0.65 (0.49, 0.85) 0.021 <0.001 1.00 (reference) 0.76 (0.66, 0.87) 0.65 (0.55, 0.77) 0.72 (0.57, 0.91) 0.029 <0.001
    Vitamin C (mg/day)
    Median (Min-Max) 18.6 (1.4-25.0) 30.8 (25.0-37.1) 44.7 (37.1-54.8) 72.0 (54.9-432.7) 20.5 (0.5-28.6) 36.6 (28.6-44.7) 54.3 (44.7-66.7) 88.9 (66.7-391.2)
    Cases/PY 252/5,334 221/5,994 229/6,111 228/5,693 405/8,090 373/9,291 357/9,192 351/9,045
    Age-adjusted model 1.00 (reference) 0.78 (0.65, 0.93) 0.79 (0.66, 0.94) 0.84 (0.71, 1.01) 0.215 0.017 1.00 (reference) 0.90 (0.78, 1.03) 0.97 (0.83, 1.12) 1.01 (0.87, 1.17) 0.550 0.227
    Multivariable model 1 1.00 (reference) 0.72 (0.60, 0.86) 0.69 (0.57, 0.83) 0.70 (0.57, 0.87) 0.011 0.002 1.00 (reference) 0.85 (0.74, 0.98) 0.89 (0.76, 1.04) 0.87 (0.73, 1.04) 0.295 0.125
    Multivariable model 2 1.00 (reference) 0.66 (0.54, 0.79) 0.59 (0.48, 0.74) 0.56 (0.42, 0.75) 0.002 <0.001 1.00 (reference) 0.79 (0.68, 0.91) 0.78 (0.65, 0.93) 0.69 (0.55, 0.88) 0.011 0.057
    Vitamin E (mg/day)
    Median (Min-Max) 2.0 (0.0- 2.8) 3.5 (2.8-4.3) 5.2 (4.3-6.3) 8.2 (6.3-27.6) 1.6 (0.0-2.4) 3.1 (2.4-3.9) 4.8 (3.9-6.0) 7.9 (6.0-36.9)
    Cases/PY 250/5,286 225/6,041 214/6,205 241/5,600 431/8,164 376/9,263 326/9,418 353/8,773
    Age-adjusted model 1.00 (reference) 0.79 (0.66, 0.93) 0.73 (0.61, 0.87) 0.91 (0.76, 1.08) 0.514 0.001 1.00 (reference) 0.88 (0.77, 1.01) 0.79 (0.68, 0.92) 0.97 (0.84, 1.13) 0.830 0.002
    Multivariable model 1 1.00 (reference) 0.74 (0.62, 0.89) 0.65 (0.53, 0.79) 0.76 (0.60, 0.97) 0.087 <0.001 1.00 (reference) 0.84 (0.73, 0.97) 0.74 (0.63, 0.86) 0.86 (0.71, 1.03) 0.121 0.001
    Multivariable model 2 1.00 (reference) 0.74 (0.61, 0.89) 0.65 (0.52, 0.80) 0.76 (0.57, 1.00) 0.183 <0.001 1.00 (reference) 0.81 (0.70, 0.94) 0.69 (0.58, 0.82) 0.75 (0.60, 0.94) 0.026 0.001
    Carotenoids (mg/day)
    Median (Min-Max) 2.1 (0.0-3.1) 4.0 (3.1-5.0) 6.2 (5.0-8.0) 11.0 (8.0-119.3) 2.3 (0.0-3.5) 4.7 (3.5-5.9) 7.3 (5.9-9.3) 12.8 (9.3-120.3)
    Cases/PY 266/5,286 210/5,979 223/6,115 231/5,752 396/8,009 390/9,140 338/9,376 362/9,093
    Age-adjusted model 1.00 (reference) 0.70 (0.59, 0.83) 0.72 (0.61, 0.86) 0.80 (0.67, 0.95) 0.127 <0.001 1.00 (reference) 0.94 (0.82, 1.08) 0.86 (0.74, 1.00) 0.99 (0.85, 1.15) 0.978 0.073
    Multivariable model 1 1.00 (reference) 0.65 (0.55, 0.78) 0.63 (0.53, 0.76) 0.66 (0.54, 0.81) 0.003 <0.001 1.00 (reference) 0.92 (0.80, 1.06) 0.81 (0.69, 0.94) 0.87 (0.74, 1.03) 0.125 0.059
    Multivariable model 2 1.00 (reference) 0.62 (0.52, 0.74) 0.58 (0.48, 0.71) 0.58 (0.46, 0.74) 0.001 <0.001 1.00 (reference) 0.87 (0.76, 1.01) 0.73 (0.62, 0.87) 0.74 (0.60, 0.91) 0.006 0.040
    Flavonoids (mg/day)
    Median (Min-Max) 44.8 (2.2-66.0) 87.4 (66.0-111.9) 144.9 (112.1-193.5) 293.7 (193.6-1,982.4) 50.5 (0.7-75.6) 101.8 (75.6-134.6) 177.1 (134.7-239.8) 350.6 (239.8-2,484.9)
    Cases/PY 255/5,264 211/6,012 230/6,039 234/5,817 392/8,029 380/9,202 373/9,444 341/8,943
    Age-adjusted model 1.00 (reference) 0.72 (0.61, 0.86) 0.78 (0.66, 0.93) 0.83 (0.69, 0.99) 0.351 0.001 1.00 (reference) 0.98 (0.85, 1.12) 1.02 (0.88, 1.18) 1.06 (0.91, 1.24) <0.001 0.869
    Multivariable model 1 1.00 (reference) 0.70 (0.58, 0.83) 0.72 (0.60, 0.87) 0.72 (0.58, 0.88) 0.183 0.001 1.00 (reference) 0.96 (0.83, 1.11) 0.95 (0.81, 1.11) 0.94 (0.79, 1.12) 0.121 0.868
    Multivariable model 2 1.00 (reference) 0.68 (0.56, 0.82) 0.70 (0.58, 0.86) 0.69 (0.54, 0.88) 0.118 <0.001 1.00 (reference) 0.94 (0.81, 1.09) 0.92 (0.78, 1.09) 0.90 (0.74, 1.11) 0.435 0.764
    Model1 Men (n=4,422)
    		 plinearity2 pnon-linearity3 Women (n=6,957)
    		 plinearity2 pnon-linearity3
    Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
    Flavonols (mg/day)
    Median (Min- Max) 6.8 (0.2-9.4) 11.9 (9.4-14.5) 17.7 (14.6- 22.1) 29.3 (22.1-245.7) 6.3 (0.0-9.0) 11.5 (9.0-14.5) 17.7 (14.5-22.8) 31.8 (22.8-219.2)
    Cases/PY 240/5,296 202/6,131 247/6,139 241/5,566 415/8,042 392/9,258 321/9,570 358/8,748
    Age-adjusted model 1.00 (reference) 0.73 (0.61, 0.87) 0.89 (0.75, 1.06) 0.95 (0.80, 1.14) 0.520 0.001 1.00 (reference) 0.93 (0.81, 1.06) 0.79 (0.68, 0.91) 1.01 (0.87, 1.17) 0.720 0.001
    Multivariable model 1 1.00 (reference) 0.69 (0.57, 0.82) 0.78 (0.64, 0.93) 0.78 (0.64, 0.95) 0.183 0.001 1.00 (reference) 0.88 (0.76, 1.01) 0.71 (0.61, 0.82) 0.85 (0.73, 1.01) 0.121 <0.001
    Multivariable model 2 1.00 (reference) 0.65 (0.54, 0.78) 0.69 (0.56, 0.85) 0.63 (0.48, 0.82) 0.019 <0.001 1.00 (reference) 0.81 (0.70, 0.93) 0.60 (0.51, 0.71) 0.63 (0.50, 0.78) <0.001 <0.001
    Flavones (mg/day)
    Median (Min-Max) 0.7 (0.0-0.9) 1.2 (0.9-1.4) 1.7 (1.4-2.1) 2.7 (2.1-12.6) 0.7 (0.0-1.0) 1.3 (1.0-1.6) 1.9 (1.6-2.4) 3.3 (2.4-14.9)
    Cases/PY 221/5,424 236/6,018 221/6,148 252/5,542 419/8,125 367/9,155 337/9,526 363/8,812
    Age-adjusted model 1.00 (reference) 0.96 (0.81, 1.15) 0.88 (0.74, 1.06) 1.12 (0.94, 1.34) 0.174 0.079 1.00 (reference) 0.89 (0.77, 1.02) 0.84 (0.73, 0.98) 1.05 (0.90, 1.22) 0.316 0.006
    Multivariable model 1 1.00 (reference) 0.88 (0.74, 1.06) 0.79 (0.65, 0.96) 0.95 (0.77, 1.17) 0.818 0.030 1.00 (reference) 0.83 (0.72, 0.96) 0.75 (0.64, 0.87) 0.88 (0.74, 1.04) 0.300 0.001
    Multivariable model 2 1.00 (reference) 0.85 (0.71, 1.03) 0.75 (0.61, 0.93) 0.88 (0.67, 1.15) 0.588 0.014 1.00 (reference) 0.78 (0.67, 0.90) 0.67 (0.57, 0.79) 0.72 (0.58, 0.90) 0.018 <0.001
    Flavanones (mg/day)
    Median (Min-Max) 0.7 (0.0-1.7) 2.8 (1.7-4.2) 5.9 (4.2, 8.5) 12.9 (8.5-137.6) 1.2 (0.0-2.8) 4.5 (2.8-6.5) 9.1 (6.6-12.8) 19.5 (12.8-192.4)
    Cases/PY 279/4,884 215/6,123 213/6,277 223/5,848 434/7,537 347/9,474 372/9,389 333/9,218
    Age-adjusted model 1.00 (reference) 0.61 (0.52, 0.73) 0.59 (0.50, 0.70) 0.66 (0.56, 0.79) 0.003 <0.001 1.00 (reference) 0.70 (0.61, 0.81) 0.82 (0.71, 0.94) 0.80 (0.69, 0.93) 0.134 <0.001
    Multivariable model 1 1.00 (reference) 0.61 (0.51, 0.72) 0.57 (0.48, 0.68) 0.62 (0.52, 0.75) 0.001 <0.001 1.00 (reference) 0.69 (0.60, 0.79) 0.79 (0.68, 0.91) 0.75 (0.64, 0.88) 0.035 <0.001
    Multivariable model 2 1.00 (reference) 0.61 (0.51, 0.73) 0.58 (0.49, 0.70) 0.64 (0.53, 0.79) 0.004 <0.001 1.00 (reference) 0.68 (0.59, 0.79) 0.78 (0.68, 0.91) 0.73 (0.62, 0.87) 0.033 <0.001
    Flavan-3-ols (mg/day)
    Median (Min-Max) 2.9 (0.0-5.8) 9.6 (5.8-16.1) 28.0 (16.1, 47.9) 127.7 (48.0-1,755.8) 3.4 (0.0-7.1) 11.8 (7.1-19.0) 33.9 (19.0-57.6) 139.2 (57.7-1,808.2)
    Cases/PY 247/5,179 230/5,951 207/5,935 246/6,066 402/7,849 367/9,198 373/9,025 344/9,546
    Age-adjusted model 1.00 (reference) 0.81 (0.68, 0.96) 0.73 (0.61, 0.87) 0.84 (0.71, 1.00) 0.682 0.002 1.00 (reference) 0.88 (0.77, 1.02) 1.00 (0.87, 1.16) 0.93 (0.80, 1.08) 0.748 0.130
    Multivariable model 1 1.00 (reference) 0.82 (0.69, 0.98) 0.69 (0.57, 0.83) 0.79 (0.65, 0.95) 0.353 0.001 1.00 (reference) 0.88 (0.76, 1.02) 0.95 (0.82, 1.10) 0.86 (0.73, 1.00) 0.145 0.214
    Multivariable model 2 1.00 (reference) 0.84 (0.70, 1.00) 0.70 (0.57, 0.85) 0.79 (0.65, 0.97) 0.409 0.002 1.00 (reference) 0.87 (0.76, 1.01) 0.94 (0.80, 1.10) 0.84 (0.71, 1.00) 0.130 0.190
    Anthocyanins (mg/day)
    Median (Min-Max) 0.8 (0.0-1.7) 2.9 (1.7-4.2) 5.9 (4.2-8.3) 13.7 (8.3-149.9) 1.2 (0.0-2.5) 4.0 (2.5-5.9) 8.2 (5.9-12.3) 19.4 (12.3-224.7)
    Cases/PY 274/4,949 233/5,989 200/6,146 223/6,047 418/7,784 373/9,331 348/9,519 347/8,984
    Age-adjusted model 1.00 (reference) 0.70 (0.59, 0.83) 0.58 (0.49, 0.70) 0.66 (0.56, 0.79) 0.001 <0.001 1.00 (reference) 0.83 (0.72, 0.96) 0.82 (0.71, 0.95) 0.90 (0.77, 1.04) 0.557 0.010
    Multivariable model 1 1.00 (reference) 0.69 (0.58, 0.82) 0.54 (0.44, 0.65) 0.60 (0.49, 0.72) <0.001 <0.001 1.00 (reference) 0.85 (0.74, 0.98) 0.78 (0.67, 0.91) 0.85 (0.73, 1.00) 0.215 0.009
    Multivariable model 2 1.00 (reference) 0.69 (0.58, 0.82) 0.54 (0.45, 0.65) 0.60 (0.49, 0.74) <0.001 <0.001 1.00 (reference) 0.84 (0.73, 0.97) 0.77 (0.66, 0.90) 0.83 (0.70, 0.99) 0.194 0.007
    Isoflavones (mg/day)
    Median (Min-Max) 5.8 (0.2-8.7) 11.7 (8.7-14.9) 19.5 (14.9-25.9) 37.8 (25.9-157.1) 5.8 (0.0-8.5) 11.3 (8.5-14.5) 19.3 (14.5-25.1) 35.7 (25.1-190.8)
    Cases/PY 247/5,025 244/5,961 205/6,437 234/5,709 415/7,824 368/9,041 319/9,671 384/9,082
    Age-adjusted model 1.00 (reference) 0.83 (0.70, 0.99) 0.65 (0.54, 0.77) 0.83 (0.70, 0.99) 0.119 <0.001 1.00 (reference) 0.83 (0.72, 0.95) 0.69 (0.60, 0.80) 0.88 (0.77, 1.01) 0.239 <0.001
    Multivariable model 1 1.00 (reference) 0.78 (0.66, 0.94) 0.60 (0.49, 0.72) 0.75 (0.62, 0.91) 0.032 <0.001 1.00 (reference) 0.81 (0.70, 0.93) 0.67 (0.58, 0.78) 0.81 (0.70, 0.95) 0.055 <0.001
    Multivariable model 2 1.00 (reference) 0.78 (0.65, 0.93) 0.59 (0.48, 0.72) 0.73 (0.59, 0.91) 0.044 <0.001 1.00 (reference) 0.79 (0.69, 0.91) 0.64 (0.55, 0.75) 0.75 (0.63, 0.88) 0.010 <0.001
    Proanthocyanidins (mg/day)
    Median (Min-Max) 10.7 (0.0-18.4) 25.7 (18.4-34.2) 45.8 (34.3-61.7) 89.6 (61.7-1,138.7) 14.7 (0.0-24.0) 34.0 (24.1-45.3) 61.6 (45.3-85.4) 126.5 (85.4-836.5)
    Cases/PY 253/5,017 245/5,873 215/6,203 217/6,038 411/7,855 392/9,090 346/9,537 337/9,136
    Age-adjusted model 1.00 (reference) 0.82 (0.70, 0.98) 0.68 (0.57, 0.82) 0.71 (0.59, 0.85) <0.001 0.014 1.00 (reference) 0.91 (0.80, 1.05) 0.83 (0.71, 0.95) 0.89 (0.77, 1.04) 0.207 0.075
    Multivariable model 1 1.00 (reference) 0.80 (0.67, 0.95) 0.59 (0.49, 0.71) 0.60 (0.49, 0.73) <0.001 0.001 1.00 (reference) 0.87 (0.76, 1.00) 0.78 (0.67, 0.91) 0.81 (0.68, 0.95) 0.034 0.039
    Multivariable model 2 1.00 (reference) 0.79 (0.66, 0.94) 0.58 (0.48, 0.70) 0.59 (0.47, 0.74) <0.001 <0.001 1.00 (reference) 0.87 (0.75, 1.00) 0.76 (0.65, 0.89) 0.77 (0.63, 0.93) 0.023 0.036
    Table 1. Age-adjusted characteristics of study participants by quartile of dTAC

    Values are presented as mean±standard error for continuous variables and % for categorical variables; Mean values with different superscripts (a, b, c) within a row exhibited significant differences among the exposure groups on the Tukey multiple comparison test.

    dTAC, dietary total antioxidant capacity; VCE, vitamin C equivalent; Q, quartile; Min, minimum; Max, maximum.

    Using the general linear model (Tukey multiple comparison).

    Linear trends were obtained by treating the median value of each group as a continuous variable.

    Higher education level (≥12 years of schooling).

    Regular exercise (≥3 times/wk and ≥30 min/session).

    Nutrient intakes were adjusted for total energy intake using the residual method.

    Table 2. Incidence rate ratios and 95% confidence intervals of MetS by quartile of dTAC and intake of 5 antioxidant classes (n=11,379)

    MetS, metabolic syndrome; VCE, vitamin C equivalents; dTAC, dietary total antioxidant capacity; Q, quartile; Min, minimum; Max, maximum; PY, person-year.

    Multivariable model 1 was adjusted for age (years), higher education level (≥12 years of schooling), regular exercise (≥3 times/wk and ≥30 min/session), smoking status (current/past/never-smokers for men and current/non-smokers for women), drinking status (yes or no), body mass index (kg/m2), and total energy intake (kcal/day) in men and women.

    Multivariable model 2 was adjusted for glycemic index, calcium (mg/day), fiber (g/day), magnesium (mg/day), sodium (mg/day), and all covariates in multivariable model 1.

    Linear trends were obtained by treating the median value of each group as a continuous variable.

    Non-linear trends were obtained by comparing the deviance difference between the linear trend model with 1 degree of freedom and the ℓ ordered categorical model with ℓ−1 degrees of freedom.

    Table 3. Incidence rate ratios and 95% confidence intervals of MetS by quartile of intake of 7 flavonoid subclasses (n=11,379)

    MetS, metabolic syndrome; Q, quartile; Min, minimum; Max, maximum; PY, person-year.

    Multivariable model 1 was adjusted for age (years), higher education level (≥12 years of schooling), regular exercise (≥3 times/wk and ≥30 min/session), smoking status (current/past/never-smokers for men and current/non-smokers for women), drinking status (yes or no), body mass index (kg/m2), and total energy intake (kcal/day) in men and women.

    Multivariable model 2 was adjusted for glycemic index, calcium (mg/day), fiber (g/day), magnesium (mg/day), sodium (mg/day), and all covariates in multivariable model 1.

    Linear trends were obtained by treating the median value of each group as a continuous variable.

    Non-linear trends were obtained by comparing the deviance difference between the linear trend model with 1 degree of freedom and the ℓ ordered categorical model with ℓ−1 degrees of freedom.

    Table 1.

    Table 2.

    Table 3.

    Epidemiol Health : Epidemiology and Health
    © Korean Society of Epidemiology.
    TOP